Physician profile
Lisa Bean
NPI 1629461082
$1,014.27
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $130 · 2023: $432 · 2024: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $255.74 | 2021-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $209.96 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $121.07 | 2023 | Eliquis |
| Jazz Pharmaceuticals INC. | $97.69 | 2023-2024 | |
| Inspire Medical Systems, INC. | $77.06 | 2023 | Inspire |
| Fisher & Paykel Healthcare INC | $49.83 | 2024 | Fisher & Paykel Healthcare |
| Lilly USA, LLC | $47.26 | 2022 | |
| Inogen, INC. | $37.95 | 2023-2024 | Inogen |
| Harmony Biosciences LLC | $32.69 | 2023-2024 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.78 | 2021 | |
| Mylan Specialty L.P. | $28.80 | 2024 | Yupelri |
| Amgen INC. | $24.44 | 2024 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Bean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.